182 related articles for article (PubMed ID: 17152347)
1. Effect of ketoconazole and rifampicin on the pharmacokinetics of ranitidine in healthy human volunteers: a possible role of P-glycoprotein.
Machavaram KK; Gundu J; Yamsani MR
Drug Metabol Drug Interact; 2006; 22(1):47-65. PubMed ID: 17152347
[TBL] [Abstract][Full Text] [Related]
2. Effect of ketoconazole on the pharmacokinetics of ornidazole--a possible role of p-glycoprotein and CYP3A.
Ramesh S; Kumar YS; Rao YM
Drug Metabol Drug Interact; 2006; 22(1):67-77. PubMed ID: 17152348
[TBL] [Abstract][Full Text] [Related]
3. Effects of Ketoconazole and Rifampicin on the Pharmacokinetics of Nintedanib in Healthy Subjects.
Luedtke D; Marzin K; Jungnik A; von Wangenheim U; Dallinger C
Eur J Drug Metab Pharmacokinet; 2018 Oct; 43(5):533-541. PubMed ID: 29500603
[TBL] [Abstract][Full Text] [Related]
4. Regional difference in intestinal drug absorption as a measure for the potential effect of P-glycoprotein efflux transporters.
Ashmawy SM; El-Gizawy SA; El Maghraby GM; Osman MA
J Pharm Pharmacol; 2019 Mar; 71(3):362-370. PubMed ID: 30362574
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the permeability of H2 receptor antagonists cimetidine and ranitidine by P-glycoprotein in rat intestine and the human colonic cell line Caco-2.
Collett A; Higgs NB; Sims E; Rowland M; Warhurst G
J Pharmacol Exp Ther; 1999 Jan; 288(1):171-8. PubMed ID: 9862768
[TBL] [Abstract][Full Text] [Related]
6. Effects of a concomitant single oral dose of rifampicin on the pharmacokinetics of pravastatin in a two-phase, randomized, single-blind, placebo-controlled, crossover study in healthy Chinese male subjects.
Deng S; Chen XP; Cao D; Yin T; Dai ZY; Luo J; Tang L; Li YJ
Clin Ther; 2009 Jun; 31(6):1256-63. PubMed ID: 19695392
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and bioequivalence of ranitidine and bismuth derived from two compound preparations.
Zhou Q; Ruan ZR; Yuan H; Jiang B; Xu DH
World J Gastroenterol; 2006 May; 12(17):2742-8. PubMed ID: 16718762
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of rosuvastatin when coadministered with rifampicin in healthy males: a randomized, single-blind, placebo-controlled, crossover study.
Zhang W; Deng S; Chen XP; Zhou G; Xie HT; He FY; Cao D; Li YJ; Zhou HH
Clin Ther; 2008 Jul; 30(7):1283-9. PubMed ID: 18691987
[TBL] [Abstract][Full Text] [Related]
9. The interaction of saquinavir (soft gelatin capsule) with ketoconazole, erythromycin and rifampicin: comparison of the effect in healthy volunteers and in HIV-infected patients.
Grub S; Bryson H; Goggin T; Lüdin E; Jorga K
Eur J Clin Pharmacol; 2001 May; 57(2):115-21. PubMed ID: 11417442
[TBL] [Abstract][Full Text] [Related]
10. Evidence of efflux-mediated and saturable absorption of rifampicin in rat intestine using the ligated loop and everted gut sac techniques.
Mariappan TT; Singh S
Mol Pharm; 2004; 1(5):363-7. PubMed ID: 16026006
[TBL] [Abstract][Full Text] [Related]
11. Role of cytochrome p450 isoenzymes 3A and 2D6 in the in vivo metabolism of mirabegron, a β3-adrenoceptor agonist.
Lee J; Moy S; Meijer J; Krauwinkel W; Sawamoto T; Kerbusch V; Kowalski D; Roy M; Marion A; Takusagawa S; van Gelderen M; Keirns J
Clin Drug Investig; 2013 Jun; 33(6):429-40. PubMed ID: 23625188
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic Evaluation of the Interactions of Amenamevir (ASP2151) with Ketoconazole, Rifampicin, Midazolam, and Warfarin in Healthy Adults.
Kusawake T; den Adel M; Groenendaal-van de Meent D; Garcia-Hernandez A; Takada A; Kato K; Ohtsu Y; Katashima M
Adv Ther; 2017 Nov; 34(11):2466-2480. PubMed ID: 29076107
[TBL] [Abstract][Full Text] [Related]
13. Effect of rifampicin pretreatment on the oral bioavailability of domperidone in healthy human volunteers.
Devandla A; Yamsani SK; Yamsani MR
Drug Metab Pers Ther; 2015 Dec; 30(4):257-61. PubMed ID: 26353177
[TBL] [Abstract][Full Text] [Related]
14. The effects of ketoconazole and rifampicin on the pharmacokinetics of mirodenafil in healthy Korean male volunteers: an open-label, one-sequence, three-period, three-treatment crossover study.
Shin KH; Kim BH; Kim TE; Kim JW; Yi S; Yoon SH; Cho JY; Shin SG; Jang IJ; Yu KS
Clin Ther; 2009 Dec; 31(12):3009-20. PubMed ID: 20110038
[TBL] [Abstract][Full Text] [Related]
15. Establishing an in vitro permeation model to predict the in vivo sex-related influence of PEG 400 on oral drug absorption.
Mai Y; Murdan S; Awadi M; Basit AW
Int J Pharm; 2018 May; 542(1-2):280-287. PubMed ID: 29530563
[TBL] [Abstract][Full Text] [Related]
16. The effect of ketoconazole on the in vivo intestinal permeability of fexofenadine using a regional perfusion technique.
Tannergren C; Knutson T; Knutson L; Lennernäs H
Br J Clin Pharmacol; 2003 Feb; 55(2):182-90. PubMed ID: 12580990
[TBL] [Abstract][Full Text] [Related]
17. Effect of rifampicin pretreatment on the transport across rat intestine and oral pharmacokinetics of ornidazole in healthy human volunteers.
Kumar YS; Ramesh S; Rao YM; Paradkar AR
Drug Metabol Drug Interact; 2007; 22(2-3):151-63. PubMed ID: 17708065
[TBL] [Abstract][Full Text] [Related]
18. Effect of food and ranitidine on saquinavir pharmacokinetics and gastric pH in healthy volunteers.
Kakuda TN; Falcon RW
Pharmacotherapy; 2006 Aug; 26(8):1060-8. PubMed ID: 16863482
[TBL] [Abstract][Full Text] [Related]
19. The impact of co-administration of ketoconazole and rifampicin on the pharmacokinetics of apremilast in healthy volunteers.
Liu Y; Zhou S; Wan Y; Wu A; Palmisano M
Br J Clin Pharmacol; 2014 Nov; 78(5):1050-7. PubMed ID: 24962564
[TBL] [Abstract][Full Text] [Related]
20. P-glycoprotein expression in the gastrointestinal tract of male and female rats is influenced differently by food.
Dou L; Mai Y; Madla CM; Orlu M; Basit AW
Eur J Pharm Sci; 2018 Oct; 123():569-575. PubMed ID: 30118850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
